Zobrazeno 1 - 10
of 405
pro vyhledávání: '"William T Williams"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mercer, Valerie J.
Publikováno v:
Bulletin of the Detroit Institute of Arts; 2012, Vol. 86 Issue 1-4, p112-113, 2p
Autor:
Darshana Jani, Robin Marsden, Michele Gunsior, Laura Schild Hay, Bethany Ward, Kyra J. Cowan, Mitra Azadeh, Breann Barker, Liching Cao, Kristin R. Closson, Kelly Coble, Sanjay L. Dholakiya, Julie Dusseault, Amanda Hays, Carina Herl, Michael E. Hodsdon, Susan C. Irvin, Susan Kirshner, Gerry Kolaitis, Nadia Kulagina, Seema Kumar, Ching Ha Lai, Francesco Lipari, Susana Liu, Keith D. Merdek, Ioana R. Moldovan, Reza Mozaffari, Luying Pan, Corina Place, Veerle Snoeck, Marta Starcevic Manning, Dennis Stocker, Magdalena Tary-Lehmann, Amy Turner, Inna Vainshtein, Daniela Verthelyi, William T. Williams, Haoheng Yan, Weili Yan, Lili Yang, Lin Yang, Jennifer Zemo, Zhandong Don Zhong
Publikováno v:
The AAPS journalReferences. 24(6)
A clear scientific and operational need exists for harmonized bioanalytical immunogenicity study reporting to facilitate communication of immunogenicity findings and expedient review by industry and health authorities. To address these key bioanalyti
Autor:
Susan Zolla-Pazner, Allan deCamp, Peter B Gilbert, Constance Williams, Nicole L Yates, William T Williams, Robert Howington, Youyi Fong, Daryl E Morris, Kelly A Soderberg, Carmela Irene, Charles Reichman, Abraham Pinter, Robert Parks, Punnee Pitisuttithum, Jaranit Kaewkungwal, Supachai Rerks-Ngarm, Sorachai Nitayaphan, Charla Andrews, Robert J O'Connell, Zhi-yong Yang, Gary J Nabel, Jerome H Kim, Nelson L Michael, David C Montefiori, Hua-Xin Liao, Barton F Haynes, Georgia D Tomaras
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e87572 (2014)
UnlabelledIn the RV144 HIV-1 vaccine efficacy trial, IgG antibody (Ab) binding levels to variable regions 1 and 2 (V1V2) of the HIV-1 envelope glycoprotein gp120 were an inverse correlate of risk of HIV-1 infection. To determine if V1V2-specific Abs
Externí odkaz:
https://doaj.org/article/908050f48a3743e69cae612588e66678
Autor:
John-Henry Lee Dean, William T. Williams, Michael N. Moulton, Mayank Patel, Michael S. Cahill, Bryan Ramsey
Publikováno v:
Journal of the American College of Cardiology. 79:2375
Autor:
ROBERTS, THOMAS
Publikováno v:
Y Cyfaill (Caerefrog, NY); Mai1874, Vol. 37 Issue 449, p188-189, 2p
Autor:
Kevin Wiehe, Barton F. Haynes, David Easterhoff, William T. Williams, Connor Hart, Todd Bradley, Thomas B. Kepler, Mattia Bonsignori, Kevin O. Saunders, William J. Faison, S. Munir Alam, Ryan Meyerhoff
SUMMARYHIV-1 broadly neutralizing antibodies (bnAbs) require high levels of activation-induced cytidine deaminase (AID) catalyzed somatic mutations for optimal neutralization potency. Probable mutations occur at sites of frequent AID activity, while
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47e9f2d6f7b1961cffe216c42cb63f87
https://doi.org/10.1101/262592
https://doi.org/10.1101/262592
Autor:
Jonathan L. Heeney, Willy M. J. M. Bogers, Nicole L. Yates, Xiaoying Shen, Loic Martin, Frederick H. Jaeger, Susan W. Barnett, Guido Ferrari, Celia C. LaBranche, Georgia D. Tomaras, Indresh K. Srivastava, Kevin Wiehe, Sheetal Sawant, David C. Montefiori, Antu K. Dey, William T. Williams, S. Munir Alam
Publikováno v:
Journal of Virology
Journal of Virology, American Society for Microbiology, 2017, 91 (19), ⟨10.1128/JVI.00401-17⟩
Journal of Virology, American Society for Microbiology, 2017, 91 (19), ⟨10.1128/JVI.00401-17⟩
Evaluation of the epitope specificities, locations (systemic or mucosal), and effector functions of antibodies elicited by novel HIV-1 immunogens engineered to improve exposure of specific epitopes is critical for HIV-1 vaccine development. Utilizing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::142c34bf2e44116220447469572d053e
https://www.repository.cam.ac.uk/handle/1810/265893
https://www.repository.cam.ac.uk/handle/1810/265893
Publikováno v:
American Journal of Therapeutics. 25:e717-e718
Autor:
Agneta von Gegerfelt, David Venzon, Kate E. Broderick, Georgia D. Tomaras, Wensheng Huang, Vainav Patel, Vanessa M. Hirsch, Welkin E. Johnson, William T. Williams, Rama Rao Amara, Viraj Kulkarni, Brandon F. Keele, Yongjun Guan, Jeffrey D. Lifson, Xiaoying Shen, Michael Piatak, Antonio Valentin, Margherita Rosati, George N. Pavlakis, Rashmi Jalah, Harriet L. Robinson, Barbara K. Felber, Julian W. Bess, Niranjan Y. Sardesai, Candido Alicea
Publikováno v:
Proceedings of the National Academy of Sciences. 110:2975-2980
We have previously shown that macaques vaccinated with DNA vectors expressing SIVmac239 antigens developed potent immune responses able to reduce viremia upon high-dose SIVmac251 challenge. To further improve vaccine-induced immunity and protection,